clinical trial · NCT04861259
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Hoffmann-La Roche·phase3·active not recruiting·n = 83
Atypical Hemolytic Uremic SyndromeCrovalimab
brief summary
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
started
Oct 22, 2021
primary completion
Oct 9, 2025
completion
Aug 20, 2029
last updated
Apr 23, 2026
official title
A Phase III, Multicenter, Single-Arm Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol